# Dexmedetomidine Combined With Lidocaine Infusion Affect Inflammation Cytokines

> **NCT03276533** · NA · COMPLETED · sponsor: **Anqing Municipal Hospital** · enrollment: 160 (actual)

## Conditions studied

- Anesthesia; Reaction

## Interventions

- **DRUG:** Saline
- **DRUG:** Lidocaine
- **DRUG:** Dexmedetomidine
- **DRUG:** Lidocaine plus Dexmedetomidine

## Key facts

- **NCT ID:** NCT03276533
- **Lead sponsor:** Anqing Municipal Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2020-08-06
- **Final completion:** 2020-08-10
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2022-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03276533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03276533, "Dexmedetomidine Combined With Lidocaine Infusion Affect Inflammation Cytokines". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03276533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*